keyword
MENU ▼
Read by QxMD icon Read
search

Cardiology guidelines

keyword
https://www.readbyqxmd.com/read/29899377/the-new-2017-acc-aha-guideline-for-classification-of-hypertension-changes-in-prevalence-of-hypertension-among-adults-in-bangladesh
#1
Gulam Muhammed Al Kibria, Krystal Swasey, Allysha Choudhury, Vanessa Burrowes, Kristen A Stafford, S M Iftekhar Uddin, Mohammadhassan Mirbolouk, Atia Sharmeen, Angela Kc, Dipak K Mitra
We analyzed the Bangladesh Demographic and Health Survey 2011 data to examine absolute differences in hypertension prevalence according to the hypertension definition of the "2017 American College of Cardiology/American Heart Association (2017 ACC/AHA) Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults" and "Seventh Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7)" 2003 guidelines. Among 7839 participants ≥35 years, the JNC7 and 2017 ACC/AHA classified 25...
June 13, 2018: Journal of Human Hypertension
https://www.readbyqxmd.com/read/29899017/statin-eligibility-coronary-artery-calcium-and-subsequent-cardiovascular-events-according-to-the-2016-united-states-preventive-services-task-force-uspstf-statin-guidelines-mesa-multi-ethnic-study-of-atherosclerosis
#2
Michael D Miedema, Zeina A Dardari, Sina Kianoush, Salim S Virani, Joseph Yeboah, Thomas Knickelbine, Veit Sandfort, Carlos J Rodriguez, Khurram Nasir, Michael J Blaha
BACKGROUND: The potential impact of the 2016 United States Preventive Services Task Force (USPSTF) guidelines on statins for primary prevention of atherosclerotic cardiovascular disease (ASCVD) warrants further analysis. METHODS AND RESULTS: We studied participants from MESA (Multi-Ethnic Study of Atherosclerosis) aged 40 to 75 years and not on statins. We compared statin eligibility at baseline (2000-2002) and over follow-up between USPSTF and the 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines...
June 13, 2018: Journal of the American Heart Association
https://www.readbyqxmd.com/read/29898842/early-impact-of-guideline-publication-on-angiotensin-receptor-neprilysin-inhibitor-use-among-patients-hospitalized-for-heart-failure
#3
Nancy Luo, Nicholas G Ballew, Emily C O'Brien, Melissa A Greiner, Pamela N Peterson, Bradley G Hammill, N Chantelle Hardy, Warren K Laskey, Paul A Heidenreich, Chun-Lan Chang, Adrian F Hernandez, Lesley H Curtis, Robert J Mentz, Gregg C Fonarow
BACKGROUND: On May 20, 2016, US professional organizations in cardiology published joint treatment guidelines recommending the use of angiotensin-receptor neprilysin inhibitor (ARNI) for eligible patients with heart failure with reduced ejection fraction (HFrEF). Using data from the Get With The Guidelines-Heart Failure registry, we evaluated the early impact of this update on temporal trends in ARNI prescription. METHODS: We analyzed patients with HFrEF who were eligible for ARNI prescription (EF ≤40%, no contraindications) and hospitalized from February 20, 2016, through August 19, 2016-allowing for 13weeks before and after guideline publication...
June 2018: American Heart Journal
https://www.readbyqxmd.com/read/29898839/does-clinician-reported-lipid-guideline-adoption-translate-to-guideline-adherent-care-an-evaluation-of-the-patient-and-provider-assessment-of-lipid-management-palm-registry
#4
Angela Lowenstern, Shuang Li, Ann Marie Navar, Salim Virani, L Veronica Lee, Michael J Louie, Eric D Peterson, Tracy Y Wang
BACKGROUND: The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol guideline recommends statin treatment based on patients' predicted atherosclerotic cardiovascular disease (ASCVD) risk. Whether clinician-reported guideline adoption translates to implementation into practice is unknown. OBJECTIVES: We aimed to compare clinician lipid management in hypothetical scenarios versus observed practice. METHODS: The PALM Registry asked 774 clinicians how they would treat 4 hypothetical scenarios of primary prevention patients with: (1) diabetes; (2) high 10-year ASCVD risk (≥7...
June 2018: American Heart Journal
https://www.readbyqxmd.com/read/29898219/association-of-patient-perceptions-of-cardiovascular-risk-and-beliefs-on-statin-drugs-with-racial-differences-in-statin-use-insights-from-the-patient-and-provider-assessment-of-lipid-management-registry
#5
Michael G Nanna, Ann Marie Navar, Pearl Zakroysky, Qun Xiang, Anne C Goldberg, Jennifer Robinson, Veronique L Roger, Salim S Virani, Peter W F Wilson, Joseph Elassal, L Veronica Lee, Tracy Y Wang, Eric D Peterson
Importance: African American individuals face higher atherosclerotic cardiovascular disease risk than white individuals; reasons for these differences, including potential differences in patient beliefs regarding preventive care, remain unknown. Objective: To evaluate differences in statin use between white and African American patients and identify the potential causes for any observed differences. Design, Setting, and Participants: Using the 2015 Patient and Provider Assessment of Lipid Management (PALM) Registry data, we compared statin use and dosing between African American and white outpatient adults who were potentially eligible for primary or secondary prevention statins...
June 13, 2018: JAMA Cardiology
https://www.readbyqxmd.com/read/29893840/translating-guidelines-into-practice-for-the-management-of-atrial-fibrillation-results-of-an-european-heart-rhythm-association-survey
#6
Gheorghe-Andrei Dan, Konstantinos Iliodromitis, Daniel Scherr, Francisco Marín, Radoslaw Lenarczyk, Heidi L Estner, Marcin Kostkiewicz, Nikolaos Dagres, Gregory Y H Lip
Despite the huge progress made in the both understanding the mechanisms and the management of atrial fibrillation (AF) this arrhythmia still represents an important health and social burden. Atrial fibrillation is increasing in frequency and is a major cause of death, stroke, heart failure, cognitive decline, and hospitalizations. New data have emerged emphasizing the multidisciplinary approach to better management of this common arrhythmia. Despite the availability of AF management guidelines, practice among European centres may differ from the current guideline recommendations...
June 8, 2018: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/29892472/pharmacological-interventions-effective-in-improving-exercise-capacity-in-heart-failure
#7
REVIEW
Cristiana Vitale, Spoletini Ilaria, Giuseppe Mc Rosano
Heart failure (HF) is characterised by exercise intolerance, which substantially impairs quality of life (QOL) and prognosis. The aim of this review is to summarise the state of the art on pharmacological interventions that are able to improve exercise capacity in HF. Ivabradine, trimetazidine and intravenous iron are the only drugs included in the European Society of Cardiology HF guidelines that have consistently been shown to positively affect functional capacity in HF. The beneficial effects on HF symptoms, physical performance and QOL using these pharmacological approaches are described...
May 2018: Cardiac Failure Review
https://www.readbyqxmd.com/read/29892468/what-is-heart-failure-with-mid-range-ejection-fraction-a-new-subgroup-of-patients-with-heart-failure
#8
REVIEW
Sunil K Nadar, Osama Tariq
Since the publication of European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) in 2016, a new class of HF has been defined, namely HF with mildly reduced ejection fraction (HFmrEF). Although the name was new, there had long been awareness of the existence of a grey area between the two established classes of HF: HF with reduced ejection fraction and HF with preserved ejection fraction. Patients between these two classes were previously either excluded from HF studies or were included in the other groups...
May 2018: Cardiac failure review
https://www.readbyqxmd.com/read/29888611/trimetazidine-in-the-prevention-of-tissue-ischemic-conditions
#9
Manolis S Kallistratos, Leonidas E Poulimenos, Sofia Giannitsi, Pavlos Tsinivizov, Athanasios J Manolis
Trimetazidine (TMZ) is a metabolic agent with significant anti-ischemic properties. By inhibiting the terminal enzyme in the β-oxidation pathway, it shifts the energy substrate metabolism, enhancing glucose metabolism. Thus, it maintains the required energy production with less oxygen consumption, an effect necessary in cases of myocardi. Trimetazidine was recently reaccredited as add-on therapy for symptomatic treatment in patients with stable angina, not adequately controlled or intolerant to first-line therapy...
January 1, 2018: Angiology
https://www.readbyqxmd.com/read/29887180/perioperative-and-periprocedural-management-of-antithrombotic-therapy-consensus-document-of-sec-sedar-seacv-sectcv-aec-secpre-sepd-sego-sehh-seth-semergen-semfyc-semg-semicyuc-semi-semes-separ-senec-seo-sepa-servei-secot-and-aeu
#10
David Vivas, Inmaculada Roldán, Raquel Ferrandis, Francisco Marín, Vanessa Roldán, Antonio Tello-Montoliu, Juan Miguel Ruiz-Nodar, Juan José Gómez-Doblas, Alfonso Martín, Juan Vicente Llau, María José Ramos-Gallo, Rafael Muñoz, Juan Ignacio Arcelus, Francisco Leyva, Fernando Alberca, Raquel Oliva, Ana María Gómez, Carmen Montero, Fuat Arikan, Luis Ley, Enrique Santos-Bueso, Elena Figuero, Antonio Bujaldón, José Urbano, Rafael Otero, Juan Francisco Hermida, Isabel Egocheaga, José Luis Llisterri, José María Lobos, Ainhoa Serrano, Olga Madridano, José Luis Ferreiro
During the last few years, the number of patients receiving anticoagulant and antiplatelet therapy has increased worldwide. Since this is a chronic treatment, patients receiving it can be expected to need some kind of surgery or intervention during their lifetime that may require treatment discontinuation. The decision to withdraw antithrombotic therapy depends on the patient's thrombotic risk versus hemorrhagic risk. Assessment of both factors will show the precise management of anticoagulant and antiplatelet therapy in these scenarios...
June 7, 2018: Revista Española de Cardiología
https://www.readbyqxmd.com/read/29885787/oral-anticoagulation-therapy-in-atrial-fibrillation-patients-managed-in-the-emergency-department-compared-to-cardiology-outpatient-opportunities-for-improved-outcomes
#11
Geetanjali Rangnekar, Celine Gallagher, Geoffrey R Wong, Simon Rocheleau, Anthony G Brooks, Jeroen M L Hendriks, Melissa E Middeldorp, Adrian D Elliott, Rajiv Mahajan, Prashanthan Sanders, Dennis H Lau
INTRODUCTION: Recent registry data suggests oral anticoagulation (OAC) usage remains suboptimal in atrial fibrillation (AF) patients. The aim of our study was to determine if rates of appropriate use of OAC in individuals with AF differs between the emergency department (ED) and cardiac outpatient clinic (CO). METHODS: This was a retrospective study of consecutive AF patients over a 12-month period. Data from clinical records, discharge summaries and outpatient letters were independently reviewed by two investigators...
April 4, 2018: Heart, Lung & Circulation
https://www.readbyqxmd.com/read/29878156/management-of-patients-with-ventricular-arrhythmias-and-prevention-of-sudden-cardiac-death-translating-guidelines-into-practice-results-of-the-european-heart-rhythm-association-survey
#12
Kristina H Haugaa, Gheorghe-Andrei Dan, Konstantinos Iliodromitis, Radoslaw Lenarczyk, Germanas Marinskis, Joaquin Osca, Daniel Scherr, Nikolaos Dagres
Prevention of sudden cardiac death (SCD) remains a partly unsolved task in cardiology. The European Society of Cardiology (ESC) guidelines on management of patients with ventricular arrhythmias and prevention of SCD published in 2015 considered the new insights of the natural history of diseases predisposing to SCD. The guidelines improved strategies for management of patients at risk of SCD and included both drug and device therapies. The intention of this survey was to evaluate the extent of the disparities between daily clinical practice and the 2015 SCD ESC guidelines among electrophysiology centres in Europe...
June 5, 2018: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology
https://www.readbyqxmd.com/read/29877659/treatment-of-heart-failure-with-preserved-ejection-fraction
#13
Alfredo Monteverde, Valeria Carlino, Giulia Ganci, Giuseppe Taormina, Mario Barbagallo
Heart failure, in its diverse forms based on the value of the ejection fraction, is associated to high mortality and the frequent need for hospitalization, with a consequent heavy burden on healthcare resources. For an appropriate treatment of heart failure with preserved ejection fraction (HFpEF), there are no specific drugs effective for this condition. Those indicated in HF with reduced EF (HFrEF) are of more benefit in that form of HF, according to the guidelines of the European Society of Cardiology of 2016: ACE-inhibitors, beta-blockers, anti-aldosterones are all indicated with a class of recommendation/level of evidence IA; therapy with loop diuretics is indicated in the case of clinical congestion (IB)...
June 7, 2018: Monaldi Archives for Chest Disease, Archivio Monaldi Per le Malattie del Torace
https://www.readbyqxmd.com/read/29877602/correlation-with-invasive-left-ventricular-filling-pressures-and-prognostic-relevance-of-the-echocardiographic-diastolic-parameters-used-in-the-2016-esc-heart-failure-guidelines-and-in-the-2016-ase-eacvi-recommendations-a-systematic-review-in-patients-with
#14
Jan F Nauta, Yoran M Hummel, Peter van der Meer, Carolyn S P Lam, Adriaan A Voors, Joost P van Melle
AIMS: Five echocardiographic parameters-left atrial volume index, left ventricular mass index, tricuspid regurgitation velocity, myocardial tissue velocity, and the ratio of early mitral inflow to tissue velocity of the mitral annulus (E/e')-are recommended in both the current European Society of Cardiology heart failure guidelines and the American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations for the evaluation of left ventricular diastolic function...
June 7, 2018: European Journal of Heart Failure
https://www.readbyqxmd.com/read/29875135/nationwide-impact-of-the-2017-american-college-of-cardiology-american-heart-association-blood-pressure-guidelines-on-stroke-survivors
#15
Alain Lekoubou, Kinfe G Bishu, Bruce Ovbiagele
BACKGROUND: In this study, we aimed at estimating the prevalence and number of stroke survivors with hypertension, recommended pharmacological treatment, and above blood pressure target, according to the 2017 American College of Cardiology/American Heart Association guidelines and the seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure guidelines. METHODS AND RESULTS: We included participants aged ≥20 years to the National Health and Nutrition Examination Surveys between 2003 and 2014...
June 6, 2018: Journal of the American Heart Association
https://www.readbyqxmd.com/read/29874141/cardiovascular-disease-in-survivors-of-childhood-cancer-insights-into-epidemiology-pathophysiology-and-prevention
#16
Saro H Armenian, Gregory T Armstrong, Gregory Aune, Eric J Chow, Matthew J Ehrhardt, Bonnie Ky, Javid Moslehi, Daniel A Mulrooney, Paul C Nathan, Thomas D Ryan, Helena J van der Pal, Elvira C van Dalen, Leontien C M Kremer
Cardiovascular disease (CVD), which includes cardiomyopathy/heart failure, coronary artery disease, stroke, pericardial disease, arrhythmias, and valvular and vascular dysfunction, is a major concern for long-term survivors of childhood cancer. There is clear evidence of increased risk of CVD largely attributable to treatment exposures at a young age, most notably anthracycline chemotherapy and chest-directed radiation therapy, and compounded by traditional cardiovascular risk factors accrued during decades after treatment exposure...
June 6, 2018: Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
https://www.readbyqxmd.com/read/29869700/-update-on-heart-failure
#17
REVIEW
J Wintrich, I Kindermann, M Böhm
Heart failure is one of the leading diseases in internal medicine worldwide. Because of the increase in population aging, the incidence and prevalence of heart insufficiency is rising annually and is now the most frequent individual diagnosis among hospitalized patients in Germany. The mortality rate has recently been reduced, since new pharmacological options, especially the inhibition of neprilysin, have been developed; however, heart failure is still associated with a high mortality and morbidity rate. Thus, guideline-conform treatment is of crucial importance...
June 5, 2018: Herz
https://www.readbyqxmd.com/read/29867293/consensus-document-anmco-ance-arca-gicr-iacpr-gise-sicoa-long-term-antiplatelet-therapy-in-patients-with-coronary-artery-disease
#18
Michele Massimo Gulizia, Furio Colivicchi, Maurizio Giuseppe Abrignani, Marco Ambrosetti, Nadia Aspromonte, Gabriella Barile, Roberto Caporale, Giancarlo Casolo, Emilia Chiuini, Andrea Di Lenarda, Pompilio Faggiano, Domenico Gabrielli, Giovanna Geraci, Alessio Gaetano La Manna, Aldo Pietro Maggioni, Alfredo Marchese, Ferdinando Maria Massari, Gian Francesco Mureddu, Giuseppe Musumeci, Federico Nardi, Antonio Vittorio Panno, Roberto Franco Enrico Pedretti, Massimo Piredda, Enrico Pusineri, Carmine Riccio, Roberta Rossini, Fortunato Scotto di Uccio, Stefano Urbinati, Ferdinando Varbella, Giovanni Battista Zito, Leonardo De Luca
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) and/or those receiving coronary stents. Long-term (>1 year) DAPT may further reduce the risk of stent thrombosis after a percutaneous coronary intervention (PCI) and may decrease the occurrence of non-stent-related ischaemic events in patients with ACS. Nevertheless, compared with aspirin alone, extended use of aspirin plus a P2Y12 receptor inhibitor may increase the risk of bleeding events that have been strongly linked to adverse outcomes including recurrent ischaemia, repeat hospitalisation and death...
May 2018: European Heart Journal Supplements: Journal of the European Society of Cardiology
https://www.readbyqxmd.com/read/29863317/hypertension-update-current-guidelines
#19
Anthony J Viera
Hypertension affects at least 1 in 3 American adults and is a major contributor to premature mortality. Current guidelines recommend screening all adults for hypertension. Ambulatory blood pressure (BP) monitoring should be used to confirm the diagnosis of hypertension for most adults before starting antihypertensive drugs. Ambulatory BP monitoring is the preferred method but home BP monitoring is an acceptable alternative. Management of hypertension substantially reduces the risk of heart failure, stroke, and myocardial infarction...
June 2018: FP Essentials
https://www.readbyqxmd.com/read/29860370/-ten-commandments-of-esc-syncope-guidelines-2018-the-new-european-society-of-cardiology-esc-clinical-practice-guidelines-for-the-diagnosis-and-management-of-syncope-were-launched-19-march-2018-at-ehra-2018-in-barcelona
#20
keyword
keyword
73299
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"